BackSonoma Pharmaceuticals Overview

Sonoma Pharmaceuticals Current Cash

Track Sonoma Pharmaceuticals's current cash ($5.3M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$5.34M
↑ 48.07% YoYΔ $1.73M vs prior year quarter

Peer trimmed avg / median

Loading

Sonoma Pharmaceuticals Current Cash History

Loading

Sonoma Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Sonoma Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sonoma Pharmaceuticals (SNOA) FAQ

As of the most recent data (June 2026), SNOA shows a current cash of $5.3M. That compares with $3.6M in the prior-year period — up 48.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SNOA's current cash is now $5.3M (was $3.6M) — a 48.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Sonoma Pharmaceuticals is outperforming or lagging.

Tracking SNOA's current cash over time shows whether Sonoma Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $5.3M That compares with $3.6M in the prior-year period — up 48.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Sonoma Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $5.3M) with ownership activity and broader fundamentals.

Sonoma Pharmaceuticals's current cash is $5.3M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.